Ameritas Investment Company’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-100
Closed -$8.82K 1963
2021
Q1
$8.82K Buy
+100
New +$9.29K ﹤0.01% 1566
2020
Q2
Sell
-525
Closed -$34K 1483
2020
Q1
$34K Buy
+525
New +$36.8K 0.01% 826
2019
Q4
Sell
-350
Closed -$21K 1464
2019
Q3
$21K Buy
+350
New +$22.3K ﹤0.01% 916

Other funds holding TNDM

Ameritas Investment Company's TNDM Position: Q2 2021 in Review

Ameritas Investment Company sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 100 shares — an estimated $8.82K sold.

Ameritas Investment Company first reported a position in TNDM in Q3 2019 and held it in 3 quarters. The position peaked at $34K in Q1 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Ameritas Investment Company reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 100 Tandem Diabetes Care shares in Q2 2021, an estimated $8.82K.
  • Ameritas Investment Company first reported a position in Tandem Diabetes Care in Q3 2019 and held it in 3 quarters.
  • Ameritas Investment Company's Tandem Diabetes Care position peaked at $34K in Q1 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.